ATARA BIOTHERAPEUTICS, INC. (ATRA) Operating income 2016–2025
ATARA BIOTHERAPEUTICS, INC. (ATRA) annual operating income history from SEC filings — each fiscal year as reported.
$35.9MFY2025 · since FY2016: -$81.2M → $35.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.9M | +143.0% |
| FY2024 | -$83.4M | +69.8% |
| FY2023 | -$276.0M | +1.6% |
| FY2022 | -$280.5M | +17.6% |
| FY2021 | -$340.5M | -10.2% |
| FY2020 | -$309.1M | -4.5% |
| FY2019 | -$295.7M | -24.7% |
| FY2018 | -$237.1M | -95.1% |
| FY2017 | -$121.5M | -49.6% |
| FY2016 | -$81.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATRA financial trends
ATRA RevenueATRA Net incomeATRA Net marginATRA Gross profitATRA Gross marginATRA Operating marginATRA Operating cash flowATRA Free cash flowATRA Capital expendituresATRA Return on equityATRA Stock buybacksATRA Dividends paidATRA Total assetsATRA Total liabilitiesATRA Shareholders’ equityATRA overview →